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ABSTRACT  We have found that hypertonic medium inhibited the receptor-mediated  uptake 
of  the  chemotactic  peptide  N-formylnorleucylleucylphenylalanine  without  affecting  fluid- 
phase endocytosis by polymorphonuclear  leukocytes (PMNs). Morphological and biochemical 
evidence  demonstrated  that cells in  hypertonic medium  did  not accumulate  peptide  in  a 
receptor-mediated  manner. However, the cells continued to form endosomes containing fluid- 
phase markers. Furthermore, the content of these endosomes was processed normally,  i.e., 
both digested and intact material were released into the medium. The inhibition of receptor- 
mediated  uptake was a function of the tonicity.  Partial inhibition occurred  in 0.45 and 0.6 
osmolar medium  and maximal inhibition occurred  in 0.75 osmolar medium.  The inhibition 
was independent of the solute used to increase the tonicity: sodium chloride,  sucrose, and 
lactose all inhibited uptake to similar extents. Hypertonic medium had little effect on saturable 
peptide  binding.  However,  it did prevent the clustering of surface molecules as indicated by 
the  inhibition  of capping  of fluorescent  concanavalin A.  In  addition,  hypertonic  medium 
prevented the peptide-stimulated  increase in cytosolic calcium levels as measured by quin 2 
fluorescence. The tonicity dependence of the inhibition of quin 2 fluorescence paralleled the 
inhibition of receptor-mediated  uptake. 
The signals and mechanisms involved in the initiation of both 
receptor-mediated  and  fluid-phase  endocytosis  have  been 
studied for a  number of years (12).  The factors controlling 
the initiation of endocytosis vary depending on the cell type 
and specific endocytic pathway being studied. One point of 
confusion is the relationship between receptor-mediated up- 
take ofligands and the uptake of fluid-phase markers. In some 
cases, the addition  of ligand stimulates the uptake of fluid- 
phase markers while in other cases, there is no change in the 
rate of fluid accumulation by the addition of ligand (1, 3,  I l, 
13). Interpretation of this data is further confused by the fact 
that it is unknown whether all uptake occurs in one class of 
vesicles or whether there are  separate pathways of uptake. 
Marsh  and  Helenius  (7)  have  argued  that  all  fluid-phase 
uptake in baby hamster kidney cells can be accounted for by 
the volume included in coated vesicles while Haigler et al. (4) 
found that in A-431  cells the fluid-phase marker, horseradish 
peroxidase, and the specific ligand, epidermal growth factor, 
appeared within  separate, morphologically distinct  vesicles. 
This was seen even when the markers were incubated with 
the cells for as short a time as 30 s (4). 
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One approach to examining the question of the uptake and 
subsequent  fate of fluid  markers and  specific ligands is to 
develop conditions which  selectively alter one or the other 
endocytic pathway. However, treatments which  reduce the 
receptor-mediated accumulation  of ligand  often  produce a 
decrease in fluid-phase endocytosis (5, 6). We now report that 
hypertonic medium selectively inhibits receptor-mediated up- 
take without affecting fluid-phase endocytosis.  Our  studies 
show  that  in  polymorphonuclear leukocytes (PMNs), l  the 
receptor-mediated accumulation of the chemotactic peptide 
N-formylnorleucylleucylphenylalanine (f-NleLeuPhe)  is  in- 
hibited by 0.75  osmolar medium, while fluid-phase endocy- 
tosis is not affected. Endosomes containing fluid-phase mark- 
Abbreviations used in this paper:  Con A, concanavalin A; FITC, 
fluorescein  isothiocyanate; f-NleLeuPhe, N-formylnorleucylleu- 
cylphenylalanine; HBSS, Hanks' balanced salt solution; hexapeptide, 
N-formyl-NleLeuPheNleTyrLys;  hNaCi, HBSS plus 0.225 M NaC1; 
hsucrose, HBSS plus 0.45 M sucrose; Hy, hemocyanin;/~, dissocia- 
tion constant; PMN, polymorphonuclear leukocytes; RBCs, erythro- 
cytes; TCA, trichloroacetic acid; TMR, tetramethylrhodamine  iso- 
thiocyanate. 
1673 ers continue to form and deliver these markers to intracellular 
compartments where digestion occurs. This inhibition is not 
due to an effect on the binding of peptide to its receptor. In 
addition,  we  show that  0.75  osmolar  medium  completely 
prevents the peptide-stimulated increase  in cytosolic calcium 
levels  as  measured  by the  fluorescent  probe,  quin  2.  The 
inhibition of  the peptide stimulation ofquin 2 shows a similar 
dependence  on  the  tonicity as  the  inhibition  of receptor- 
mediated uptake with maximal inhibition occurring in 0.75 
osmolar medium. 
MATERIALS  AND  METHODS 
Cells:  Rabbit peritoneal exudate PMNs were collected 4 h after injection 
of 0.1  g of shellfish glycogen (Schwarz/Mann Div., Becton, Dickinson & Co., 
Orangeburg, NY) in 250 ml of 0.9% saline. Contaminating  erythrocytes (RBCs), 
if present, were lysed by a brief(60-s) treatment with hypotonic (0.18%) saline. 
The  cells were washed twice with 0.9%  saline and  resuspended  in  Hanks' 
balanced salt solution (HBSS) (Gibco Laboratories, Grand Island, NY) buffered 
with 2.4 mg/ml of HEPES (Sigma Chemicai Co., St.  Louis, MO) at a concen- 
tration of 3.3 x  l06 cells/ml. 3 ml of the cell suspension was placed in 60 x 
15-ram petri dishes (Falcon Labware, Becton, Dickinson & Co., Oxnard, CA) 
and the cells were allowed to settle for  15 min at 23"C.  Dishes were checked 
with an inverted microscope to ensure that an even monolayer had formed. 
Human PMNs were obtained from blood by venipuncture. The blood was 
mixed  with  0.6%  dextran  70  and  0.02  M  sodium  citrate  in  saline (final 
concentrations). The  RBCs were allowed to settle, the plasma layer was re- 
moved, and the cells were pelleted at 400 g for l0 rain. Contaminating RBCs 
were  lysed by exposure  to  0.18%  saline for  30  s.  Cells were  washed and 
resuspended in Ca  ++- and Mg++-free  HBSS, layered on Ficoll-Hypaque (Phar- 
macia Fine Chemicals, Piscataway, NJ), and spun 20 min at 600 g. The cell 
pellet was resuspended and washed twice in HBSS without phenol red. 
Media:  The  tonicity of the  media was adjusted  to  the  final desired 
osmolarity by the addition of the appropriate amount of sucrose, lactose, or 
sodium chloride. Cells were pretreated for l0 min at 37"C with the hypertonic 
medium prior to the start of an experiment. 
Peptide  Uptake  and Release:  Cells were  incubated for  varying 
times  with  [3H]f-NleLeuPhe  (New  England  Nuclear,  Boston,  MA;  specific 
activity I I  Ci/mM) at 37"C  and then washed for  10  rain at 4"C.  This has 
previously been shown to remove >95%  of the receptor-bound peptide (13). 
The peptide remaining cell associated after this wash is the "total uptake." 
By varying the concentration of peptide, we could follow either receptor- 
mediated or fluid-phase uptake. Rabbit peritoneal PMNs have a receptor for f- 
NleLeuPhe which has a dissociation constant, Kd, of about 2 x  l0  -s M. From 
a  dose-response curve of f-NleLeuPhe uptake, we  have determined the per- 
centage of the total uptake which occurred via a receptor-mediated process at 
each concentration of peptide (2).  Both total uptake and nonsaturable uptake 
(3H-peptide uptake in the presence of an excess of unlabeled peptide [l,000 
times the K~ concentration]) were measured.  Receptor-mediated uptake was 
calculated by subtracting nonsaturable uptake from total uptake. At concentra- 
tions of peptide <3  x  l0  -8  M,  the majority of the uptake is via a  receptor- 
mediated process, specifically, at 2  x  l0  -s M, 80% of the uptake occurs in a 
saturable manner. The accumulation of peptide at concentrations above ~3 x 
l0  -s M  is proportional to the concentration of peptide present in the extracel- 
lular medium.  At  these  high concentrations,  peptide  acts as  a  fluid-phase 
marker. At 10  -s peptide, only 1% of  the counts accumulated could be accounted 
for by a saturable process. These experimentally derived values are consistent 
with the following calculation which estimates the proportion of total uptake 
of peptide that occurs in the fluid-phase when cells are incubated with l0  -s M 
f-NleLeuPhe. At l0  -s M  f-NleLeuPhe (l,000 times the K,s concentration), all 
of the receptors should be occupied, i.e., approximately two times the number 
occupied at 2  x  l0  -8  M  (/~). Therefore, the amount of peptide taken up in 
receptor-mediated manner would be expected to be twice that observed at 2 x 
10  -8 M. In Fig.  l, where the specific activity of the  l0  -s M  peptide was 0.01 
times that of the 2  x  l0  -s M  peptide, the receptor-mediated uptake of radio- 
labeled peptide at l0  -s M f-NleLeuPhe would be expected to amount to 2% of 
the counts taken up at 2 x  10  -8 M. In this experiment, the total counts taken 
up were approximately the same for cells in  l0  -s M  and 2  ×  l0  -8 M  peptide. 
Thus 2% of the total uptake at l0  -s M  appears to be via a  receptor-mediated 
process and the remaining 98% must occur via the fluid phase. 
Fluid uptake was also measured by the uptake of [~4C]sucrose (New England 
Nuclear) and  [12SIlhemocyanin (Hy)  (iodinated as  described previously for 
bovine serum albumin [2]).  Hy degradation was monitored by precipitation 
with 10% trichloroacetic acid (TCA). 
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FIGURE  1  Effects of hypertonic medium on receptor-mediated and 
fluid-phase  uptake of f-NleLeuPhe.  PMNs  were incubated  for  30 
min at 37°C  in  either HBSS  or hNaCI  containing (A) 2  x  10  -8 M 
[3H]f-NleLeuPhe to follow receptor-mediated uptake or (B) 10  -s M 
[3H]f-NleLeuPhe  (at 0.01  times  normal specific  activity) to follow 
fluid-phase uptake. The dark bars are cells in HBSS; the white bars 
are cells in hNaCl. 
To measure release of the cell-associated radioactivity, cells were incubated 
with [aH]f-NleLeuPhe or [~2Sl]Hy, washed, and were then returned to 37°C in 
HBSS for various times. The medium was removed and counted. The radio- 
activity remaining with the cells was also counted. 
Peptide Digestion:  Peptide digestion was assayed by partitioning into 
ethyl acetate. The aqueous medium containing released cell-associated radio- 
activity was brought to pH 2  with  1 N  HC1,  and an equal volume of ethyl 
acetate was added. After thorough mixing, the solution was allowed to separate 
into  two  phases.  The  intact  f-NleLeuPhe,  having a  blocked amino  group, 
partitions into ethyl acetate and the digestion products (any molecule with a 
free amino group will be protonated at pH 2) remain in the aqueous phase. 
The radioactivity (the  s  peptide is labeled with [ H]phenylalanine) in each of the 
phases was then counted.  This analysis of peptide digestion was confirmed 
using thin layer chromatography. Hypertonic medium (regardless  of solute used 
to increase the tonicity) had no effect on the partitioning assay. 
Binding 5tudies:  Each dish containing l0  T cells was incubated in 1.0 
ml  of  HBSS  (or  the  appropriate  hypertonic  solution) with  l0  -7  M  [3H]f- 
NleLeuPhe at 4"C. After incubation, this medium was aspirated and the dish 
washed  quickly (~6  s)  and  vigorously in  two  baths  of 4"C  saline of the 
appropriate tonicity. Cell-associated radioactivity was counted.  In all experi- 
ments the dishes were monitored visually for cell loss. 
Fluorescent  Reagents:  The  chemotactic  peptide  N-formyl-Nle- 
LeuPheNleTyrLys (hexapeptide) (Sigma Chemical  Co.),  was conjugated  to 
tetramethylrhodamine isothiocyanate (TMR) (Research Organics Inc.) follow- 
ing the procedure of Niedel et al. (9).  Briefly, TMR (10 mM) was reacted with 
2.5 mM hexapeptide in dry dimethylformamide containing 1% triethylamine 
for  18 h  at 22"C.  The product TMR-hexapeptide was purified by thin layer 
chromatography in chloroform, methanol, and triethylamine  (5:2:1  by volume) 
(TMR-hexapeptide, Rf =  0.3; unconjugated hexapeptide, Rf =  0.15). Fluores- 
cein isothiocyanate-Con A (FITC-Con A) (Sigma Chemical Co.) was used at 
a  concentration of 500 #g/ml and  FITC-dextran (Sigma Chemical Co.) was 
used at a concentration of 5 mg/ml. 
Microscopy:  Cells were  viewed  by  phase-contrast  and  fluorescence 
microscopy equipped with SIT camera. Video output was recorded with a NEC 
video recorder. The images were photographed directly from the monitor. 
Quin 2 Assay:  Human cells (2 x  107 cells/ml) in HBSS without phenol 
red containing 0.1%  ovalbumin and  20 uM  acetoxymethyl ester of quin  2 
(Amersham Corp.,  Arlington Heights, IL) at pH  7.4 were incubated for 20 
min in the dark at 37"C followed by a 20-min incubation at room temperature. 
The cells were washed twice and resuspended at 107 cells/ml in HBSS without 
phenol red containing 0.1% ovalbumin and kept on ice until used. For each 
assay  l07  cells were  pelleted and  resuspended  in  2  ml  of medium  of the appropriate tonicity prewarmed to 37"C. The cells were incubated at 37"C for 
10 min before  10  -~ M  n-formyl-MetLeuPhe was added. The changes in fluO- 
rescence were measured in a  stirred cuvette in a  Perkin-Elmer spectrofluoro- 
meter (excitation at 339 nm and emission at 492 nm). Intracellular calcium 
concentration was calculated using the following equation: 
(F -  F.f) -  (F~.  -  F~..t) 
[Ca++]i. =  1.15 x  10  -7 (F.m -  Fm,~) -  (F-  F~f)' 
in which 1.15 x  10  -7 M  =  Kd for Ca  ++ binding to quin 2; F =  fluorescent signal 
in response to stimulation of cells loaded with quin 2; F.~ =  fluorescent signal 
after cells are lysed with 0.2% Triton X-100; F~a. =  fluorescent signal in lysed 
cells plus I mM EGTA; F.f, F.~.r, and F.~.,~ =  autofluorescent measurements 
in cells which have not been loaded with quin 2  (intact cells, lysed cells, and 
lysed cells plus 1 mM EGTA, respectively). 
RESULTS 
Hvpertonic Medium Inhibits Receptor-mediated 
But Not Fluid-Phase Uptake. 
The  chemotactic  peptide,  f-NleLeuPhe,  is  taken  up  by 
peritoneal PMNs in both a receptor-mediated and fluid-phase 
manner (13). By varying the concentration of peptide, we can 
follow either  receptor-mediated  or  fluid-phase  uptake  (see 
Materials and  Methods).  PMNs  have a  receptor for f-Nle- 
LeuPhe which has a dissociation constant,/G, of ~2 x  10  -8 
M. At 2 x  10  -8 M, ~80% of the peptide uptake is saturable, 
i.e.,  can be competed for with a high concentration of unla- 
beled peptide. Thus, 80% of the uptake at 2 x  l0  -8 M is via 
a receptor-mediated process. At 10  -5 M (1,000 times the/G), 
~98%  of the  peptide  uptake is accumulated via uptake of 
bulk  fluid.  We have used  2  x  l0  -8  M  f-NleLeuPhe as an 
indicator  of receptor-mediated  uptake  and  l0  -5  M  f-Nle- 
LeuPhe as a  fluid-phase marker. Placing the cells in hyper- 
tonic medium inhibited the receptor-mediated accumulation 
of f-NleLeuPhe without affecting the fluid-phase uptake of 
peptide  (Fig.  1).  The  persistence  of fluid-phase  uptake  in 
hypertonic medium was confirmed using another fluid-phase 
marker, [~4C]sucrose. Cells in hypertonic medium accumu- 
lated the  same amount of ['4C]sucrose as did  control cells 
(Fig. 2). 
Morphological  Examination of Effects of 
Hvpertonic Medium 
To examine morphologically the effect of hypertonic me- 
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FmURE  2  Effect of hypertonic medium on the uptake of the fluid- 
phase  marker,  [14C]sucrose.  PMNs  were  incubated  with  [14C]su- 
cruse (12 #Ci/ml) and 2 x  10  -a M unlabeled f-NleLeuPhe for various 
times at 37°C in HBSS (O) or in hNaCI (0). 
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hexapeptide labeled with tetramethylrhodamine (TMR-hex- 
apeptide). The hexapeptide has been shown to compete for 
the same receptor as f-NleLeuPhe (9). PMNs, exposed to 2 x 
10  -9 M TMR-hexapeptide at 37"C, accumulated fluorescence 
within  cytoplasmic organelles (both  endocytic vesicles and 
phase-dense granules) which exhibited saltatory motion (Fig. 
3,  a  and b).  The accumulation  of fluorescence was due to 
receptor-mediated uptake since it could be competively inhib- 
ited by an excess of unlabeled f-NleLeuPhe (Fig.  3, c and d). 
When PMNs were exposed to 2 x  10  -9 M TMR-hexapeptide 
in  0.75  osmolar medium (HBSS plus 0.225  M  NaCl),  the 
accumulation of fluorescence was dramatically inhibited (Fig. 
3, e and f). However, hypertonic medium had no effect on 
the accumulation of a fluorescent fluid-phase marker, FITC- 
dextran (Fig.  3,  g-j).  Similarly hypertonic medium had no 
effect on the accumulation of 10  -5 M  TMR-hexapeptide. At 
this concentration, peptide accumulation occurs primarily in 
a  fluid-phase  manner.  Thus,  hypertonic medium inhibited 
the receptor-mediated internalization of peptide but did not 
prevent the formation of endosomes involved in the uptake 
of fluid markers. 
Characterization of Inhibition 
The extent of the inhibition  of receptor-mediated uptake 
depended on the tonicity. Partial inhibition occurred in 0.45 
and 0.6 osmolar medium, while maximal inhibition occurred 
in 0.75 osmolar medium (2.5 times normal tonicity) (Fig. 4). 
The inhibition was independent of the solute used to increase 
the  tonicity.  Increasing the  tonicity  with  sodium  chloride, 
sucrose, or lactose inhibited uptake to a similar extent. The 
inhibition of receptor-mediated processes did not appear to 
occur at the level of receptor binding since incubation of cells 
30  min in  hypertonic medium at 37"C  had  little effect on 
subsequent  peptide  binding  assayed  at  4"C  in  hypertonic 
medium. In medium containing 0.45 M sucrose, the amount 
of saturably bound peptide at 2  x  10  -8 M  was  1.24  _+ 0.33 
times that bound to cells incubated in control HBSS (mean 
_+ SD, n =  8). With addition of 0.225 M  NaCl to HBSS, the 
binding was 0.96 _+ 0.13 (n =  3) of control levels. 
The inhibition  was rapid;  maximal inhibition  of uptake 
occurred within 5 rain of placing cells in hypertonic medium. 
The effect was also  rapidly  reversible.  Uptake  returned  to 
control levels within 5 min of returning the cells to isotonic 
medium, i.e., the slopes of the uptake curves were the same 5 
min after return to control medium (Fig. 5). The reversibility 
of the  inhibition  of hypertonic  medium  on  the  receptor- 
mediated accumulation was also followed morphologically. 
When  PMNs were removed from hypertonic medium  and 
placed in  isotonic medium, they accumulated TMR-hexa- 
peptide in a receptor-mediated manner. 
Hvpertonic Medium Inhibits the Capping of 
Con A 
The fluorescent signal from the TMR-hexapeptide was too 
low to determine whether hypertonicity had any effect on the 
clustering of the peptide-receptor complex. Thus, to examine 
the  effect  of hypertonic  medium  on  the  aggregation  and 
distribution of a cell surface marker, we followed the capping 
of Con A. Cells were incubated with FITC-Con A in control 
or hypertonic medium for 15 min at 37"C.  While >80% of 
cells in control medium capped the FITC-Con A, <4%  of 
the cells in hypertonic medium capped the FITC-Con A (Fig. 
AND ZIGMOND  Inhibition of Receptor But Not Fluid Endocytosis  1675 FIGURE  3  Morphological examination of the effect of hypertonicity on receptor-mediated and fluid-phase endotycosis.  PMNs 
were incubated for 30  min at 37°C  with  different fluorescent  reagents in  either HBSS or hNaCI.  Living cells were viewed by 
phase-contrast microscopy (a, c, e, g, and i) or fluorescence microscopy (b, d, f, h, and j). To monitor receptor-mediated uptake, 
cells  were  incubated  in  HBSS with  2  x  10  -9  M  TMR-hexapeptide  (a  and  b).  To  document  that  the  accumulation  of  the 
fluorescence observed in b  was due to a saturable process, cells were incubated in  HBSS with 2  x  10  -9 M  TMR-hexapeptide 
plus 10  -5 M f-NleLeuPhe to compete for receptor binding (c and d). To evaluate receptor-mediated uptake in hypertonic medium, 
cells were incubated in 2 x  10  -9 M  TMR-hexapeptide in hNaCI (e and f). To monitor fluid phase uptake, cells were incubated in 
FITC-dextran in HBSS (g and h) or in hNaCI (i and j). 
6  and  Table  I). The  cells in  hypertonic medium  showed  a 
diffuse pattern of fluorescence even after 60 min at 37"C. The 
inhibition of capping was reversible. Cells which had bound 
FITC-Con A  in  hypertonic NaC1  were  pelleted and  resus- 
pended in HBSS in the absence of FITC-Con A. The FITC- 
Con A that was bound to the cells in hypertonic medium was 
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FIGURE  4  Effect  of  increasing  tonicity  on  the  receptor-mediated 
uptake  of  peptide.  PMNs  were  incubated  with  2  x  10  -~ M  [3H]-f- 
NleLeuPhe at  37°C  for  various times  in  HBSS  (@)  or  HBSS  plus 
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FIGURE  5  Reversal  of  the  inhibition  by  hypertonic  medium  on 
receptor-mediated  uptake.  PMNs  were  pretreated  with  HBSS or 
HBSS plus 0.45  M  sucrose (hsucrose),  then  uptake was measured 
in  HBSS or  hsucrose.  Pretreatment and  uptake  in  HBSS (O);  pre- 
treatment  and  uptake  in  hsucrose (O);  pretreatment  in  hsucrose, 
uptake in HBSS (x). 
now capped (Table I). This result also demonstrates that the 
inability to visualize capping in hypertonic medium was not 
due to insufficient binding of FITC-Con A to the cell surface. 
Characterization of Processing of Endocytosed 
Material in Hypertonic Medium 
In  Fig.  3,  we  showed  that  hypertonic  medium  did  not 
prevent the  formation of endosomes containing fluid-phase 
markers. To assess whether there was any alteration of the 
intracellular fate of this endocytosed material, we examined 
the  processing of this  cell-associated material.  After PMNs 
had  accumulated peptide in  a  fluid-phase manner,  peptide 
was  removed  and  the  cells  were  incubated  in  hypertonic 
medium  at  37"C.  As  can  be  seen  in  Fig.  7a,  hypertonic 
medium did not prevent the release of either intact or digested 
peptide.  In fact, the  proportion  of f-NleLeuPhe released as 
digested peptide was slightly increased in hypertonic medium. 
We obtained similar results following the processing of an- 
other  fluid-phase  marker,  [~25I]Hy. The  uptake  of [t2~I]Hy 
and the release of digested products (TCA-soluble radioactiv- 
ity) and  intact  material  (TCA-precipitable radioactivity) in 
hypertonic medium was similar to that seen in control cells 
(Fig.  8). Thus, in hypertonic medium, endosomes containing 
fluid-phase markers appear to be processed normally. 
Although hypertonic medium inhibited the continuing ac- 
cumulation of peptide in a receptor-mediated manner, there 
was a small amount of peptide accumulation which reached 
a plateau within 5 min (Figs. 4 and 5). Upon further incuba- 
tion  in  the  absence  of peptide,  the  majority  of this  cell- 
associated peptide was released from the cells. The amount of 
intact peptide released from cells in hypertonic medium was 
FIGURE  6  Effect  of hypertonicity on capping of Con A. Cells were 
incubated  for  15  min  at  37°C  in  FITC-Con  A  in  HBSS  (a)  or  in 
hNaCl (b). 
TABLE  I.  Effect of Hypertonicity on Con A  Capping 
Cells capped after 
being washed and 
resuspended in 
Cells capped in 15 min  HBSS for 15 min at 
Media  at 37"C  37"C 
%  % 
HBSS  84 _  3.3; n --- 3*  77_  7; n =  2 
hNaCl*  3.7 +  5.3; n =  3  60 _  9; n =  2 
* n, the number of different experiments analyzed. 100 cells per sample were 
scored. The mean -_+ the standard deviation is given. 
hNaCI, HBSS  plus 0.225 M NaCI. 
the same as that seen in control cells (Fig.  7 b). The kinetics 
of the uptake and release of the pool of intact peptide were 
similar to that seen in control cells.  However, in contrast to 
that seen with fluid-phase markers, hypertonicity dramatically 
decreased  the  amount  of digested  peptide  released.  Thus, 
hypertonic medium prevented receptor-mediated peptide up- 
take and delivery of peptide into a compartment where diges- 
tion occurs but did not prevent the filling of a compartment 
from which peptide is subsequently released intact. 
DAUKAS AND ZIGMOND  Inhibition of Receptor But Not Fluid Endocytosis  1677 FIGURE 7
￿
Effect of hypertonic medium on processing of endocytosed peptide . (A) To examine the effect on the processing of
peptide accumulated in a fluid-phase manner, PMNs were incubated with 10-5 M [3H]f-NIeLeuPhe for 30 min at 37°C in HBSS
(filled bars) or in hNaCl (open bars) . The cells were washed at 4°C and returned to 37°C in HBSS or hNaCl . After 30 min, the
medium was removed and analyzed for the presence of digested and intact peptide . (e) To examine the processing of peptide
accumulated in a receptor-mediated manner, PMNs were incubated with 2 x 10-8 M [ 3H]f-NIeLeuPhe for 30 min at 37°C in
HBSS or in hNaCl . Cells were treated as above and the medium was analyzed for the presence of digested and intact peptide .
FIGURE 8
￿
Effect of hypertonic medium on the uptake and proc-
essing of [' 251]Hy . (A) Uptake : PMNs were incubated for 30 min at
37°C with [' 251]Hy (6.5 uCi/ml) in HBSS (dark bars) or in hNaCl
(white bars) . (8) Release : After a 30-min uptake at 37°C, cells were
washed at 4°C and returned to 37°C in HBSS or in hNaCl . After 30
min, the medium was removed and analyzed for the presence of
TCA-precipitable (intact) and TCA-soluble (digested) radioactivity .
Effect of Hypertonicity on Peptide-stimulated
Increase in Cytosolic Calcium
Chemotactic factors induce a rapid, transient increase in
cytosolic calcium levels which can be measured with the
fluorescent probe, quin 2 (10) . We have asked whether addi-
tion of peptide would induce an increase in cytosolic calcium
in cells in hypertonic medium . PMNs loaded with quin 2 in
HBSS were switched to media ofvarying tonicities for 10 min
at 37°C prior to peptide addition . Raising the osmolarity of
the medium to 0.75 osmolar completely prevented the quin
2 signal upon addition of 10- ' M n-formyl-MetLeuPhe (Fig .
9) . The inhibition of the peptide-stimulation of quin 2 in-
creased as the tonicity of the medium was increased and
paralleled the inhibition of receptor-mediated uptake (Fig. 9) .
DISCUSSION
We have found that hypertonic medium inhibited receptor-
mediated but not fluid-phase endocytosis by PMNs. The
effects of hypertonicity were documented biochemically and
morphologically using [ 3H]f-NIeLeuPhe and TMR-hexapep-
tide as markers ofreceptor-mediated uptake and ['°C]sucrose,
[1211]Hy, FITC-dextran, and high concentrations of [ 3H]f-
NleLeuPhe as markers of the fluid phase . We showed that
endosomes that contain fluid-phase markers continue to form
in hypertonic medium and appear to be processed normally
by the cell, i.e., some of the material taken up was released
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FIGURE 9 Effect of increasing tonicity of peptide-stimulated in-
crease in cytosolic calcium concentration . The fluorescent signal
from quin 2 containing PMNs in media of varying tonicity was
recorded both before and after addition of 10' M n-formyl-Met-
LeuPhe . The maximum stimulation of intracellular calcium concen-
tration is plotted as a function of osmolarity . The tonicity of the
medium was increased by the addition of NaCl to HBSS . Determi-
nation of intracellular calcium concentration is described in Mate-
rials and Methods .
back to the medium intact while most was digested and then
released. Hypertonic medium prevented the receptor-media-
ted uptake and delivery of peptide into a compartment where
digestion occurs but did not prevent the filling of a compart-
ment from which peptide is subsequently released intact. The
extent ofthe inhibition increased with increasingtonicity with
maximal inhibition occurring at 0.75 osmolar. The inhibition
was independent of the solute used to increase the tonicity;
sodium chloride, sucrose, and lactose all gave similar results.
The inhibition was rapid and rapidly reversible . The reversi-
bility of the effect and the persistence of fluid-phase uptake
indicated that the inhibition was not due to nonspecific
toxicity of the hypertonic medium.
Hypertonic medium appears to be unusual in its ability to
rapidly and reversibly separate fluid-phase and receptor-me-
diated endocytosis by selectively inhibiting receptor-mediated
uptake . Mostconditions reportedto inhibit receptor-mediated
uptake also inhibit fluid-phase uptake . Larkin et al . (6) found
that depletion of intracellular potassium results in the inhi-
bition of the receptor-mediated uptake of both low density
lipoprotein and epidermal growth factor and the fluid-phase
uptake of horseradish peroxidase in fibroblasts . This treat-
ment also reduced the number of coated pits (6) . Kaplan and
Keogh (5) have shown that in macrophages, the addition of
amines decreased fluid-phase pinocytosis as well as the recep-FIGURE 10  Proposed  models  for  the 
mechanism of inhibition of receptor-me- 
diated  uptake  by  hypertonic  medium. 
(A) Hypertonic medium prevents the in- 
ternalization  of  receptor-ligand  com- 
plexes. This could result from inhibition 
of  surface  receptor  clustering.  (B)  Hy- 
pertonic medium allows receptor-ligand 
internalization but  prevents movement 
of receptor-ligand complexes from a pri- 
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tot-mediated uptake  of az-macroglobulin.  The  weak bases 
were shown to decrease cell surface receptor number and to 
inhibit  aE-macroglobulin accumulation.  The mechanism of 
inhibition of fluid-phase pinocytosis was unclear (5). 
To determine if hypertonic medium inhibited transduction 
of peptide-induced signals, we examined the peptide-stimu- 
lated increase in cytosolic calcium. This is an early response 
to peptide binding. Using the fluorescent calcium probe, quin 
2,  we found that incubating cells in 0.75  osmolar medium 
completely prevented the peptide-stimulated increase in cy- 
tosolic calcium levels.  The extent of this inhibition showed a 
similar dependence on tonicity as that seen for the inhibition 
of receptor-mediated uptake. It is unknown whether the in- 
hibition of Ca  ++ mobilization and receptor-mediated uptake 
are  due  to  the  loss  of a  common  intermediate  coupling 
peptide-receptor binding to cellular responses. However, the 
similarity  in  the  dose  dependence  of the  two  phenomena 
suggests this as a possibility. 
Our data are consistent with the models pictured in Fig. 
10. In model A, hypertonicity prevents the internalization of 
surface receptor-bound peptide by preventing receptor clus- 
tering into forming endosomes. Fluid-phase material contin- 
ues to be internalized and delivered to the digestion compart- 
ment. Unclustered receptors would only inefficiently facilitate 
ligand internalization. In support of this hypothesis, we have 
shown that hypertonic medium inhibits the surface aggrega- 
tion of Con A. 
In model B, hypertonic media allows receptor-ligand inter- 
nalization but prevents their movement from a  primary re- 
cycling endosome.  In this model, both fluid-phase markers 
and  peptide-receptor complexes are  internalized  in  hyper- 
tonic medium into a  reversible pinocytic compartment (re- 
cycling endosome pool). Fluid-phase material can be delivered 
to the lysosomal compartment where digestion occurs but the 
peptide-receptor complex remains in  a  reversible pinocytic 
compartment which is in steady-state with the cell surface. 
Mellman et al. (8) have presented a similar model to explain 
the recycling of the Fc receptor. They suggest that the state of 
the receptor aggregation may determine whether an internal- 
ized receptor remains in an endosome pool from which it can 
be recycled back to the cell surface or is removed from this 
pool and delivered to the lysosomes. 
A third model would hypothesize two separate pathways of 
uptake; one for fluid-phase and a second for receptor-media- 
~'  Receptor-ligand complex 
A  Fluid-phase marker 
ted uptake. In this case, hypertonicity would selectively inhibit 
the pathway for receptor-mediated uptake. 
Whichever model turns  out to be right,  the  relationship 
between the  binding  and  internalization  of receptor-ligand 
complexes and the uptake of soluble markers is of interest in 
understanding the factors involved in the initiation of endo- 
cytosis as well as those  factors important in the sorting of 
constituents  within  endosomal  (pre-lysosomal)  compart- 
ments. Hypertonic medium will be a useful tool with which 
to investigate the initial steps involved in the endocytic path- 
way. 
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